Pharmaceuticals

Mystery bidder withdraws from takeover battle for cancer drugmaker Allos

11 Oct 2011

Teva wins US regulatory approval for $6.8-bn Cephalon acquisition

08 Oct 2011

Teva's acquisition of Cephalon was approved after it agreed to divest rights to generic versions of sleep disorder medicine Provigil and two other drugs in order to preserve competition

Medical diagnostics firm Axis-Shield bows to Alere’s raised offer of £235 mn

07 Oct 2011

Japan’s Holdings to buy US-based Caris Life Sciences for $725 million

07 Oct 2011

Carlyle, Hellman & Friedman to buy drug research firm PPD for $3.9 bn

05 Oct 2011

PPD, which provides outsourced clinical research and laboratory services to drug companies, also invests in developing new products through its compound partnering programme.

Government plans 6 more national centres for pharma education and research

01 Oct 2011

US FDA approves two new chemopathy drugs by Strides subsidiary Onco Therapies

30 Sep 2011

Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million

29 Sep 2011

Ipca Labs looks to acquire pharma unit in Indonesia

28 Sep 2011

Patented drugs overpriced, admits Glaxo CEO Witty

28 Sep 2011

The industry has to strike a balance between delivering innovation and affordable pricing, particularly in emerging markets and least developed countries, says GSK chief executive Andrew Witty.

JB Chemicals, Dr Reddy's call of Russia-CIS business deal

26 Sep 2011

Johnson & Johnson recalls anaemia drug Eprex in 17 countries

24 Sep 2011

J&J is recalling around 200,000 syringes of the anemia drug Eprex in 17 countries due to inconsistent potency in dosages

New trial for retinal stem cell treatment approved

23 Sep 2011

Sun Pharma resolves FDA issue at US plant

19 Sep 2011

European drug regulator approves Strides' oncology injectible Oxaliplatin

16 Sep 2011

Jubilant arm in $70-million OTC drug manufacturing contract with US firm

14 Sep 2011

S Africa’s Aspen Pharma targets $800-mn foreign acquisitions

14 Sep 2011

India to emerge among top players in pharma industry by 2020

13 Sep 2011

Biocon to set biopharmaceutical plant, R&D centre in Malaysia

12 Sep 2011

Ranbaxy to launch generic ‘Lipitor’ in US by November

09 Sep 2011

Ranbaxy Laboratories, India’s largest drugmaker, will launch a generic version of Lipitor, the world’s top-selling cholesterol control drug, in the US by November

Lupin, Sanofi-Aventis Philippines in strategic agreement

05 Sep 2011

Ranbaxy’s subsidiary launches esomeprazole in UK

05 Sep 2011

US drug standards agency expands testing facility in India

02 Sep 2011

Dr Reddy’s launches OTC generic of Sanofi's Allegra

31 Aug 2011

Cipla, Lupin deny in stake sale talks with Takeda

25 Aug 2011